Cargando…

Hypersensitivity to Biological Treatments in Juvenile Idiopathic Arthritis: How Should It Be Managed?

Juvenile idiopathic arthritis (JIA) is one of the most frequent diseases in the practice of pediatric rheumatology. JIA treatments have been modified and improved with the use of biological drugs along with technological innovations. However, different types of hypersensitivity reactions to biologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasap Cuceoglu, Muserref, Basaran, Ozge, Soyer, Ozge, Ozen, Seza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785630/
https://www.ncbi.nlm.nih.gov/pubmed/36555908
http://dx.doi.org/10.3390/jcm11247291